Generally speaking, Lebanon's pharmaceutical overall market size is small by regional - as well as global - standards, limited by a population of around 6mn. Lebanon's pharmaceutical market is calculated to have been worth LBP2.75trn (USD1.82bn) in 2017, accounting for 3.5% of the country's GDP and 44% of total healthcare expenditure. This translates into per capita spending of USD299 - substantially higher than regional spending for Arab Gulf Levant countries. Most of the market is accounted for by prescription medicines, which represents 82% of the total value. This situation is supported by the widespread use of patented drugs (at 61% of total prescription spending, which is boosted by the fear of counterfeits and high per capita incomes) and relatively high prices of branded generic drugs. Nevertheless, cost-containment pressures and patent expirations are expected to contribute to higher usage of non-patented medicines in the future.

Key View

SWOT

Industry Forecast

Pharmaceutical Market Forecast

Healthcare Market Forecast

Prescription Drug Market Forecast

Patented Drug Market Forecast

Generic Drug Market Forecast

OTC Medicine Market Forecast

Pharmaceutical Trade Forecast

Industry Risk/Reward Index

MENA Innovative Pharmaceuticals Risk/Reward Index

Lebanon Innovative Pharmaceuticals Risk/Reward Index

Regulatory Development

Regulatory Review

Market Overview

Competitive Landscape

Company Profile

Algorithm

Pharmaline

Lebanon Demographic Outlook

Pharmaceuticals & Healthcare Glossary

Pharmaceuticals & Healthcare Methodology